PRKN and Parkinson disease: In vivo, USP14 inhibition corrected mitochondrial dysfunction and locomotion impairment in the established PINK1 and Parkin mutant Drosophila model of neurodegeneration, highlighting the potential of USP14 inhibitors as therapeutics for PD symptoms.